BRPI0508660A - composição de vacina eficaz na prevenção ou melhora da infecção por vìrus da doença bursal infecciosa; composição de vacina; isolado antigênico do vìrus da doença bursal infecciosa; e método para induzir proteção contra infecção do vìrus da doença bursal infecciosa - Google Patents

composição de vacina eficaz na prevenção ou melhora da infecção por vìrus da doença bursal infecciosa; composição de vacina; isolado antigênico do vìrus da doença bursal infecciosa; e método para induzir proteção contra infecção do vìrus da doença bursal infecciosa

Info

Publication number
BRPI0508660A
BRPI0508660A BRPI0508660-4A BRPI0508660A BRPI0508660A BR PI0508660 A BRPI0508660 A BR PI0508660A BR PI0508660 A BRPI0508660 A BR PI0508660A BR PI0508660 A BRPI0508660 A BR PI0508660A
Authority
BR
Brazil
Prior art keywords
disease virus
bursal disease
infectious bursal
vaccine composition
virus infection
Prior art date
Application number
BRPI0508660-4A
Other languages
English (en)
Inventor
Jeffrey Harold Rodenberg
Mahesh Kumar
Kalen Cookson
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34994418&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0508660(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0508660A publication Critical patent/BRPI0508660A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSIçãO DE VACINA EFICAZ NA PREVENçãO OU MELHORA DA INFECçãO POR VìRUS DA DOENçA BURSAL INFECCIOSA; COMPOSIçãO DE VACINA; ISOLADO ANTIGêNICO DO VìRUS DA DOENçA BURSAL INFECCIOSA; E MéTODO PARA INDUZIR PROTEçãO CONTRA INFECçãO DO VìRUS DA DOENçA BURSAL INFECCIOSA. Trata-se de isolados antigênicos e vacinas contra o vírus da Doença Bursal Infecciosa que incluem variantes da família do Grupo 6 molecular de isolados IBDV, em particular, o isolado28-1.
BRPI0508660-4A 2004-03-12 2005-03-10 composição de vacina eficaz na prevenção ou melhora da infecção por vìrus da doença bursal infecciosa; composição de vacina; isolado antigênico do vìrus da doença bursal infecciosa; e método para induzir proteção contra infecção do vìrus da doença bursal infecciosa BRPI0508660A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55298904P 2004-03-12 2004-03-12
PCT/US2005/007879 WO2005089795A2 (en) 2004-03-12 2005-03-10 Infectious bursal disease virus antigenic isolates and vaccines

Publications (1)

Publication Number Publication Date
BRPI0508660A true BRPI0508660A (pt) 2007-08-14

Family

ID=34994418

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0508660-4A BRPI0508660A (pt) 2004-03-12 2005-03-10 composição de vacina eficaz na prevenção ou melhora da infecção por vìrus da doença bursal infecciosa; composição de vacina; isolado antigênico do vìrus da doença bursal infecciosa; e método para induzir proteção contra infecção do vìrus da doença bursal infecciosa

Country Status (17)

Country Link
US (3) US7338661B2 (pt)
EP (2) EP2272949A3 (pt)
JP (1) JP4845874B2 (pt)
KR (1) KR101172921B1 (pt)
CN (1) CN1930284B (pt)
AR (1) AR048429A1 (pt)
AU (1) AU2005222604B2 (pt)
BR (1) BRPI0508660A (pt)
CA (1) CA2557844C (pt)
CL (1) CL2010001175A1 (pt)
CO (1) CO5721019A2 (pt)
ES (1) ES2608599T3 (pt)
IL (1) IL177903A (pt)
MX (1) MXPA06010377A (pt)
NZ (1) NZ549687A (pt)
WO (1) WO2005089795A2 (pt)
ZA (1) ZA200607609B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2272949A3 (en) * 2004-03-12 2011-01-19 Wyeth LLC Infectious bursal disease virus antigenic isolates and vaccines
KR101511712B1 (ko) * 2013-04-03 2015-04-13 주식회사 카브 신규 전염성 ｆ낭병 바이러스 ｉｂｄ ｋ7주 및 이를 이용한 전염성 ｆ낭병 백신
KR20180129926A (ko) * 2016-06-02 2018-12-05 조에티스 서비시즈 엘엘씨 감염성 기관지염에 대한 백신
CN108126191B (zh) * 2016-12-01 2021-04-06 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
CN108653724B (zh) * 2017-04-01 2020-11-27 普莱柯生物工程股份有限公司 一种用于预防禽减蛋综合征的疫苗组合物、及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US6471962B1 (en) 1987-06-14 2002-10-29 The University Of Maryland Monoclonal antibodies for infectious bursal disease, vaccines and assays for use therewith
US5192539A (en) 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
US5614409A (en) * 1989-05-30 1997-03-25 Commonwealth Scientific And Industrial Research Organisation Production of IBDV VP2 in highly immunogenic form
NZ235474A (en) 1989-10-18 1992-12-23 Univ Maryland Virus capable of inducing infectious bursal disease; assay and vaccine
US5919461A (en) 1989-10-18 1999-07-06 Akzo Nobel N.V. Nonpathogenic infectious bursal disease virus and vaccine
JPH05501064A (ja) * 1990-05-04 1993-03-04 ユニバーシティ　オブ　メリーランド　アット　カレッジ　パーク Ｉｂｄｖタンパク質に関連する特異的ｄｎａ配列並びにベクター、宿主およびワクチン
US5595912A (en) * 1990-05-04 1997-01-21 University Of Maryland College Park Specific DNA and RNA sequences associated with US IBDV variants, vector carrying DNA sequences, host carrying cloned vector, deduced amino acid sequences, vaccine and method of vaccination
IL103939A (en) 1992-12-01 1996-09-12 Abic Ltd An anti-DBI vaccine in birds containing attenuated live DBI virus
US5605792A (en) * 1993-11-04 1997-02-25 The Ohio State University Research Foundation Infectious bursal disease virus VP2 fusion protein expressed by baculovirus, use as diagnostic
US5788970A (en) * 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
CN1202378A (zh) * 1997-06-02 1998-12-23 财团法人化学及血清疗法研究所 使用细胞系来制备传染性囊病病毒及禽呼肠病毒的方法
US6159472A (en) * 1998-11-16 2000-12-12 Akzo Nobel N.V. Intradermal Avian immunization with inactivated vaccines
US6764684B2 (en) * 2001-09-28 2004-07-20 Zeon Corporation Avian herpesvirus-based recombinant infectious bursal disease vaccine
WO2003074552A1 (en) * 2002-03-01 2003-09-12 Akzo Nobel N.V. An infectious bursal disease virus variant
KR101085310B1 (ko) * 2003-03-24 2011-11-22 인터벳 인터내셔널 비.브이. 감염성 점액낭병 바이러스 돌연변이체 및 백신
EP2272949A3 (en) * 2004-03-12 2011-01-19 Wyeth LLC Infectious bursal disease virus antigenic isolates and vaccines

Also Published As

Publication number Publication date
KR101172921B1 (ko) 2012-08-13
AU2005222604A1 (en) 2005-09-29
EP1722814B1 (en) 2016-11-09
IL177903A0 (en) 2006-12-31
CO5721019A2 (es) 2007-01-31
JP2007528900A (ja) 2007-10-18
WO2005089795A3 (en) 2006-02-23
CA2557844C (en) 2016-06-21
US7338661B2 (en) 2008-03-04
AR048429A1 (es) 2006-04-26
US20050266019A1 (en) 2005-12-01
CN1930284A (zh) 2007-03-14
US8323658B2 (en) 2012-12-04
MXPA06010377A (es) 2007-02-14
WO2005089795A2 (en) 2005-09-29
CN1930284B (zh) 2010-06-23
ZA200607609B (en) 2008-07-30
EP2272949A2 (en) 2011-01-12
NZ549687A (en) 2008-08-29
EP1722814A2 (en) 2006-11-22
EP2272949A3 (en) 2011-01-19
US20080193480A1 (en) 2008-08-14
CL2010001175A1 (es) 2011-04-08
JP4845874B2 (ja) 2011-12-28
KR20060130726A (ko) 2006-12-19
IL177903A (en) 2015-04-30
US20110123560A1 (en) 2011-05-26
CA2557844A1 (en) 2005-09-29
AU2005222604B2 (en) 2011-08-11
ES2608599T3 (es) 2017-04-12

Similar Documents

Publication Publication Date Title
MX2023000411A (es) Vacuna combinada de sars-cov-2 e influenza.
BRPI0716518B8 (pt) vacina de ipv e uso da mesma
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
MY169275A (en) Method of immunization against the four serotypes of dengue
PT1187629E (pt) Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
AR020134A1 (es) Antigenos inmunologicos contra el virus herpes simplex y metodos para el uso de los mismos
BR112022016507A2 (pt) Vacinas contra o coronavírus e métodos de uso
MX2009004223A (es) Protocolo de inmunizacion contra los 4 serotipos del dengue.
WO2007124479A3 (en) Avian influenza viruses, vaccines, compositions, formulations, and methods
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
MXPA04000680A (es) Vacuna para virus west nile.
DK1326636T3 (da) Vaccinesammensætning
CO6460752A2 (es) Respuesta inmunitaria reforzada en especies aviares
WO2007002470A3 (en) Inactivated chimeric vaccines and related methods of use
DE69732709D1 (de) Expressionsblockierung von virulenten faktoren in s. aureus
CO5280138A1 (es) Virus atenuados e inocuos de la diarrea virica bovina para en vacas gestantes
EP1301208A4 (en) Vaccine
ATE547116T1 (de) Kombinationsimpfstoff
BR0209145A (pt) Vacina contra varìola
AR065765A1 (es) Composicion de vacuna para el tratamiento de enfermedades infecciosas respiratorias
TW200617166A (en) Multivalent avian influenza vaccines
DE69306934D1 (de) Geflügelkrankheit verursachende neue bakterie und daraus stammender impfstoff
BR112022019207A2 (pt) Composições de vacina para coronavírus e métodos de uso das mesmas
WO2001022994A3 (en) Vaccines against neisseria infection

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: WYETH LLC (US)

B25A Requested transfer of rights approved

Owner name: PAH W LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS W LLC (US)

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C12N 7/00 , C12N 7/08 , A61K 39/12 , A61K 39/15 , C07K 14/08

Ipc: A61K 39/15 (2006.01), C12N 7/01 (2006.01), C12N 15

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: ZOETIS SERVICES LLC (US)

B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]